PainReform Ltd (PRFX): Konsensus nilai wajar

The price action history of PainReform Ltd. (PRFX) on the GURU.Markets platform, where the indicator stands at 240.22, demonstrates the development trajectory of this long-term pain management systems developer. The business is protected by exclusive patents for the Plex03 platform, despite stringent FDA oversight. Stable management is currently focusing on completing tests, which, combined with the success of PRF-110 and the demand for opioid alternatives, is driving commercial growth.

PainReform Ltd (PRFX) - Target konsensus saka 04.07.2022 nganti 22.10.2026

Rincian analitis perusahaan PainReform Limited (PRFX)

PRFX — sistem indikator bursa lan keuangan PainReform Corp:

Bagan kutipan painreform.com|PRFX - Bagan rega target|Nilai pasar PainReform Limited

Analisis umum perusahaan:PRFX painreform.com

Barang unggulan PainReform Corp

The consensus forecast dynamics for the market value of PainReform Ltd. (PRFX) reflect market expectations regarding the commercial success of PainReform Ltd. (PRFX) biopolymer developments in the field of local anesthesia. This indicator represents a weighted average of target prices from leading analysts, capturing shifts in investor sentiment as new R&D data emerges, which allows for the prompt adjustment of capital management strategies based on professional valuations.

Pesaing PainReform Ltd.

HLN: Bagan tingkat prakiraan|Bagan rega target Kenvue KVUE|Konsensus nilai wajar VRNA|Jyong Biotech Corp - Prakiraan konsensus analis|Bagan tingkat prakiraan LGND|AMRX (Amneal Pharmaceuticals) - Target konsensus|Prakiraan gabungan firma investasi PRGO|Bagan rega target Alvotech SA|Liquidia Corp - Bagan tingkat prakiraan|Prakiraan konsensus analis GLPG|ANIP (ANI Pharmaceuticals Corp) - Konsensus nilai wajar|Prakiraan konsensus analis MNKD (MannKind Corporation)|Prakiraan konsensus analis amphastar.com AMPH|PCRX - Bagan rega target|Konsensus nilai wajar SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Bagan rega target|Target konsensus Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis Tectonic|Target konsensus TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Konsensus nilai wajar|Bagan rega target Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Rata-rata rega prakiraan|EXOZ: Target konsensus|Oramed Pharmaceuticals - Rega prakiraan analis|ENTX: Prakiraan konsensus analis|MindWalk Holdings, Inc. - Konsensus nilai wajar|ABVC (ABVC BioPharma Inc) - Prakiraan konsensus analis|Rata-rata rega prakiraan Cumberland Corp CPIX|Bagan rega target Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Konsensus nilai wajar|Bagan rega target Telomir Pharmaceuticals, Inc. TELO|RANI (Rani Therapeutics Holdings) - Bagan tingkat prakiraan|Synergy CHC Corporation - Prakiraan konsensus analis|RLYB - Prakiraan konsensus analis|LEXX: Prakiraan konsensus analis|PULM - Target median analis|Bagan rega target Pheton Holdings Limited|Prakiraan gabungan firma investasi APM (Aptorum)|Bagan rega target Lyra Therapeutics, Inc (LYRA)|IBO (impactbiomedinc.com) - Konsensus nilai wajar|Prakiraan konsensus analis TNFA (TNF Pharmaceuticals, Inc.)|cbdMD Inc. (YCBD) - Rata-rata rega prakiraan|Auris Medical - Prakiraan konsensus analis|Bagan tingkat prakiraan LIPO|Optinose (OPTN) - Bagan rega target|Rata-rata rega prakiraan Pieris Pharma (PIRS)|Bagan rega target Procaps Group S.A.|PTPI: Konsensus nilai wajar|Bagan rega target Qilian International Holding (QLI)|Target konsensus Acelyrin Inc. SLRN|TFF Pharma - Target konsensus